Corona virus in Southern African Region, Novel Corona virus disease Mutations in Southern African Region, Must Be Elimin

1. corona virus disease in africa Health experts are of the viewpoint that, the emergence of new strains of Covid-19 in Southern African Region, have resulted to an increase in the number of cases of Corona virus disease and loss of lives that were announced in many nations in Sub-Saharan Africa. There has been a second wave of the global pandemic, in at least forty-40 African countries, inclusive of all the countries in sub-saharan Africa, this viewpoint, was stated by the Africa Centre for Disease Control (CDC). The occurring second wave of the Covid-19 pandemic, is believed to be linked with the appearance of new variants of the Covid-19, these new mutations, are more virulent . According to the World Health Organization (W.H.O), recently, a new mutant of the Corona virus emerged in South Africa and this mutant has led to an increase in the documented numbers of cases, in the Sub-Saharan Africa. In other parts of the African continent, this new strain of the Corona virus, has been officially accounted in Tanzania, Mozambique, Zambia, Botswana, Kenya, Comoros and Ghana; there exists the probability of the novel strain of Covid-19 virus reaching other countries in the African continent, however, most countries in Africa, lack the much required financial requirements and well trained health staff, that are required to carry out extremely specialized sequencing of the genome, required to map out and confirm the new mutations of the Covid-19. According to the W.H.O, in recently conducted medical laboratory diagnostic test, results have pointed out that, the Corona virus variant of the virus in South Africa is very contagious amongst individuals. In a recent study carried out by the University of Witwatersrand, the Oxford-Astra Zeneca Corona virus vaccine, the first Corona virus vaccine that landed in South Africa, provides little remedy against mild and light cases of Corona virus, that arose from the new mutations of the Covid-19. The recent research performed by the University of Witwatersrand, did not research the vaccine's potency, in combating harsh Corona virus disease contaminations. The Oxford- AstraZeneca Corona virus disease vaccine, is a vaccine that was created by a joint venture partnership between the University of Oxford and AstraZeneca Plc; AstraZeneca Plc, is a British- Swedish multinational pharmaceutical and biotechnology corporation, that has its headquarters situated at the University of Cambridge Biomedical Campus, in Cambridge England. As of this moment, there is an immediate and pressing need, for individuals, banks, insurance companies, financial institutions, hedge funds, corporate organizations, mining companies, venture capitalists, international donors and philanthropists, to extend aid to the efforts of medical staff and medical experts, across the continent of Africa, that are working restlessly to eradicate the Corona virus disease and make sure that the Corona virus disease is totally rooted out for the good of citizens of Africa and the African continent as a whole.